Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

The disease course of COVID-19 in patients with immunodeficiencies is unclear, as well as the optimal therapeutic strategy. We report a case of a 37-year old male with common variable immunodeficiency disorder and a severe SARS-CoV-2 infection. After administration of convalescent plasma, the patien...

Full description

Bibliographic Details
Main Authors: Karel F. A. Van Damme, Simon Tavernier, Nele Van Roy, Elisabeth De Leeuw, Jozefien Declercq, Cédric Bosteels, Bastiaan Maes, Marieke De Bruyne, Delfien Bogaert, Victor Bosteels, Levi Hoste, Leslie Naesens, Piet Maes, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Pieter Depuydt, Eva Van Braeckel, Filomeen Haerynck, Bart N. Lambrecht
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Immunology
Subjects:
convalescent plasma
COVID-19
common variable immunodeficiency disorders
immunodeficiencies
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.596761/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.596761/full

Similar Items